JPRN-UMIN000030999已完成1 期
Phase I and II study of S-1+vinorelbine in patients with advanced non-small cell cancer - Phase I and II study of S-1+vinorelbine in patients with advanced non-small cell cancer
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patient with need of procedure for pleural effusion 2. Patient with need of drainage procedure for cardiac effusion 3. Patient with symptomatic brain metastasis 4. Patient with severe complications 5. Patient with interstitial pneumonia or pulmonary fibrosis diagnosed by chest X-ray 6. Female patient in or having achance or planning of pregnancy or breast feeding 7. Male patient in plannning to impregnate 8. Patient with active multiple cancers 9. Patient with history of drug hypersensitivity 10. Patient with history of hypersensitivity against vinorelbine or other vinca alkaloids 11. Patient with history of hypersensitivity against TS-1 or pyrimidine fluoride 12. Being treated with other pyrimidine fluoride 13. Being treated with flucytosine 14. Any patient judged by the investigator to be unfit to participate in the study
研究者
相似试验
招募中
2 期
Phase II Study of Vinorelbine + TS-1 in Patients with EGFR-mutated Advanced Non-small Cell Lung CancerJPRN-UMIN000016765Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University37
已完成
1 期
Phase I study of Vinorelbine(VNR) and S-1 combination therapy for the elderly patients with advanced non-small-cell lung cancer.advanced non-small-cell lung cancerJPRN-UMIN000026093Tokyo Metropolitan Tama Medical Center Department of respiratory medicine and clinical oncology9
已完成
1 期
A phase I study of vinorelbine concurrent with thoracic radiotherapy in elderly patients with l locally advanced non-small cell lung cancer(WJTOG 3005).on-small cell lung cancerJPRN-UMIN000001392West Japan Oncology Group20
进行中（未招募）
1 期
Study to assess the efficacy and safety of oral vinorelbine in combination with capecitabine in patients suffering from breast cancer previously treated with other chemotherapies (anthracyclines, and taxanes)EUCTR2004-000665-35-ESPierre Fabre Medicament
进行中（未招募）
1 期
Phase II study evaluating oral vinorelbine as a single agent in patients with hormone receptor breast cancer with bone metastases previously treated by a hormone therapyBreast cancer with bone metastases previously treated by a hormone therapy.MedDRA version: 12.1Level: LLTClassification code 10027475Term: <Manually entered code. Term in E.1.1>EUCTR2009-014497-18-FRPIERRE FABRE MEDICAMENT66